|
cardiotrophin-1 |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of ischemia-reperfusion injury in kidney transplant recipients |
| USA Market Approval | USA |
| USA Designation Date | 2014-10-16 00:00:00 |
| Sponsor | Digna Biotech, S.L.;Avenida Pio XII 22, Pamplona (Navarra); |
